Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-19-015475
Filing Date
2019-06-04
Accepted
2019-06-04 16:25:00
Documents
1
Period of Report
2019-06-01

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3486
  Complete submission text file 0000899243-19-015475.txt   4830
Mailing Address BAARERSTRASSE 14 ZUG V8 CH-6300
Business Address BAARERSTRASSE 14 ZUG V8 CH-6300 6173154600
CRISPR Therapeutics AG (Issuer) CIK: 0001674416 (see all company filings)

EIN.: 473173478 | State of Incorp.: V8 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O CRISPR THERAPEUTICS AG 200 SIDNEY STREET CAMBRIDGE MA 02139
Business Address
Kulkarni Samarth (Reporting) CIK: 0001682019 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37923 | Film No.: 19876925